Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Fortis redeems FCCBs worth $100M held by Singapore's sovereign fund GIC - The Pharma Times | Pharma & Health Care News Portal
Categories: Latest

Fortis redeems FCCBs worth $100M held by Singapore’s sovereign fund GIC

New Delhi, May 28, 2015
Fortis Healthcare Ltd, the second-largest hospital chain in the country by revenues, has redeemed $100 million worth of outstanding Foreign Currency Convertible Bonds (FCCBs) listed on the Luxembourg Stock Exchange, it said on Friday.

Singapore’s sovereign wealth fund GIC had invested around $100 million (under Rs 450 crore that time) in Fortis’ FCCB issue in May 2010. The bonds were optionally convertible at Rs 167 per share with a yield-to-maturity of 5.537 per cent per annum.

The total payout for redeeming the outstanding bonds was $105.67 million (Rs 675 crore), including the redemption premium of around $3.17 million and interest payment of $2.5 million for the preceding six months period ended May 21, 2015.

The company has made the redemption from its existing cash proceeds, it said.

Post the redemption of the FCCBs, the company’s net debt to equity ratio is estimated to be less than 0.15x as against 0.27x as on December 31, 2014.

“The FCCB redemption further strengthens our balance sheet giving us greater flexibility to pursue our agreed strategy,” Gagandeep Singh Bedi, chief financial officer of Fortis Healthcare, said.

GIC was also to put in Rs 380 crore through a preferential allotment of shares in 2010 but had deferred the plans and eventually did not invest more in the firm.

The healthcare firm had issued FCCBs to fund its takeover battle for Singapore-based Parkway Holdings. It had eventually bowed out of the race for Parkway, selling its existing stake to Malaysian sovereign fund Khazanah, that went on to build the largest Asian healthcare company under IHH.

Fortis had thereafter taken a u-turn on its international expansion strategy and gradually sold assets in Southeast Asia and Australia. Recently, Fortis Healthcare completed sale of its Singapore-based healthcare services unit RadLink-Asia Pte Ltd and its subsidiaries to Fullerton Healthcare Group for S$111 million (approximately $83.5 million or Rs 530 crore).

Fortis Healthcare stock last traded at Rs 169.75 a share, down 0.12 per cent on the BSE in a strong Mumbai market on Friday.

Given that Fortis shares are not trading at any significant premium to the pre-set conversion price of the FCCBs held by GIC, the redemption of bonds was a foregone conclusion. PTI

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

1 day ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

2 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

3 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

4 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

1 week ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420